530 related articles for article (PubMed ID: 28233184)
21. Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications.
Nadpara N; Reichenbach ZW; Ehrlich AC; Friedenberg F
Dig Dis Sci; 2020 Oct; 65(10):2769-2779. PubMed ID: 32661765
[TBL] [Abstract][Full Text] [Related]
22. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
Fiasse R; Denis MA; Dewit O
J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
[TBL] [Abstract][Full Text] [Related]
23. Integrin antagonists as potential therapeutic options for the treatment of Crohn's disease.
McLean LP; Cross RK
Expert Opin Investig Drugs; 2016; 25(3):263-73. PubMed ID: 26822204
[TBL] [Abstract][Full Text] [Related]
24. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2017 Sep; 153(3):858-859. PubMed ID: 28778399
[No Abstract] [Full Text] [Related]
26. Inflammatory Bowel Disease.
Prog Drug Res; 2016; 71():117-22. PubMed ID: 26939275
[TBL] [Abstract][Full Text] [Related]
27. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.
Holleran G; Lopetuso L; Petito V; Graziani C; Ianiro G; McNamara D; Gasbarrini A; Scaldaferri F
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934123
[TBL] [Abstract][Full Text] [Related]
28. Current medical therapy for chronic inflammatory bowel diseases.
Tamboli CP
Surg Clin North Am; 2007 Jun; 87(3):697-725. PubMed ID: 17560421
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
Hooper KM; Barlow PG; Stevens C; Henderson P
J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462
[TBL] [Abstract][Full Text] [Related]
30. Advances in inflammatory bowel diseases in children.
Michail S; Ramsy M; Soliman E
Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease.
Tighe D; McNamara D
World J Gastroenterol; 2017 Jan; 23(3):414-425. PubMed ID: 28210077
[TBL] [Abstract][Full Text] [Related]
32. Vedolizumab in the treatment of Crohn's disease.
Tarabar D; Hirsch A; Rubin DT
Expert Rev Gastroenterol Hepatol; 2016; 10(3):283-90. PubMed ID: 26810276
[TBL] [Abstract][Full Text] [Related]
33. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
34. Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Peyrin-Biroulet L
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259
[TBL] [Abstract][Full Text] [Related]
35. Anti-integrin therapy for inflammatory bowel disease.
Park SC; Jeen YT
World J Gastroenterol; 2018 May; 24(17):1868-1880. PubMed ID: 29740202
[TBL] [Abstract][Full Text] [Related]
36. Challenges and progress in pediatric inflammatory bowel disease.
Rufo PA; Bousvaros A
Curr Opin Gastroenterol; 2007 Jul; 23(4):406-12. PubMed ID: 17545777
[TBL] [Abstract][Full Text] [Related]
37. Targeting integrins and adhesion molecules to combat inflammatory bowel disease.
Marafini I; Sedda S; Pallone F; Monteleone G
Inflamm Bowel Dis; 2014 Oct; 20(10):1885-9. PubMed ID: 25215614
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
40. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Ledder O; Lemberg DA; Day AS
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
